Finance

Lists
EHC:NYSE
Encompass Health Corp
US$ १२२.५४
+०.०५%
(+०.०६०) 1D
US$ १२२.५४
०.००% (०.००)
After hours
Closed: अक्टोबर ८, १६:००:०२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHC...
Open
US$ १२२.३५
High
US$ १२३.५८
Low
US$ १२१.९४
Mkt. cap
१२.०९ अरब
Avg. vol.
९.१९ लाख
Volume
८.९६ लाख
Dividend
०.६९%
Quarterly dividend
US$ ०.२१
Ex-dividend date
२०२६ अक्टोबर १
P/E ratio
२०.००
52-wk high
US$ १२७.९९
52-wk low
US$ ९२.७७
EPS
US$ ६.१३
Beta
०.७५
Shares outstanding
९.८७ करोड
No. of employees
३० हजार
Open
US$ १२२.३५
High
US$ १२३.५८
Low
US$ १२१.९४
Mkt. cap
१२.०९ अरब
Avg. vol.
९.१९ लाख
Volume
८.९६ लाख
Dividend
०.६९%
Quarterly dividend
US$ ०.२१
Ex-dividend date
२०२६ अक्टोबर १
P/E ratio
२०.००
52-wk high
US$ १२७.९९
52-wk low
US$ ९२.७७
EPS
US$ ६.१३
Beta
०.७५
Shares outstanding
९.८७ करोड
No. of employees
३० हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
७ घण्टा पहिले
Encompass Health sets results date and EHC stock costs EUR 109.50
Yahoo Finance
Yahoo Finance
·
२१ घण्टा पहिले
Encompass Health Corporation (EHC) Stock Forecasts
Simply Wall Street
Simply Wall Street
·
१ दिन पहिले
Encompass Health (EHC) Shares Just Moved, So What Is Catching Attention?
Profile
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022. From 1996 to 2003, executives at the company committed accounting fraud on a large scale, leading to a scandal and financial restructuring. Wikipedia
About Encompass Health Corp
CEOMark J. Tarr
Employees२९.७ हजार
Founded१९८४ फेब्रुअरी २२
Headquartersबर्मिङ्गह्याम, अलाबामा, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to EHC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EHC in the last 3 months.
Highest
Current US$ १२२.५४
US$ १५५.०० (+२६.४९%)
Average
US$ १४६.७८ (+१९.७८%)
Lowest
US$ १४०.०० (+१४.२५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
US$ १४०.००
+१४.२%
10/02/2026
Andrew Cooper
Raymond James
Buy
Reiterated
US$ १५०.००
+२२.४%
09/28/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
US$ १४२.००
+१५.९%
09/18/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
US$ १४७.००
+२०%
09/17/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$ १४०.००
+१४.२%
08/11/2026
David S Macdonald
Truist Financial
Buy
Maintained
US$ १५०.००
+२२.४%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
US$ १५०.००
+२२.४%
08/07/2026
A.J. Rice
UBS
Buy
Reiterated
US$ १५५.००
+२६.५%
08/07/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
US$ १५३.००
+२४.९%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
US$ १४४.००
+१७.५%
08/06/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Reiterated
US$ १४०.००
+१४.२%
05/04/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
US$ १५०.००
+२२.४%
05/01/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
US$ १.५५ / US$ १.४८
+४.७५%beat
Revenue / Est. (USD)
१.६० अरब / १.५७ अरब
+१.६६%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४८ अरब
१.५४ अरब
१.५९ अरब
१.६० अरब
Cost of goods sold
८४.९४ करोड
८६.५६ करोड
८८.२४ करोड
८८.६४ करोड
Cost of revenue
८४.९४ करोड
८६.५६ करोड
८८.२४ करोड
८८.६४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७.१० करोड
८.८२ करोड
७.३४ करोड
७.७३ करोड
Operating expense
३८.४५ करोड
३९.५६ करोड
४०.२६ करोड
४२.२६ करोड
Total operating expenses
१.२३ अरब
१.२६ अरब
१.२८ अरब
१.३१ अरब
Operating income
२४.३६ करोड
२८.३४ करोड
३०.१६ करोड
२८.८४ करोड
Other non operating income
५९.०० लाख
३७.०० लाख
१२.०० लाख
९१.०० लाख
EBT including unusual items
२१.९९ करोड
२५.७७ करोड
२८.८७ करोड
२६.१६ करोड
EBT excluding unusual items
२१.९९ करोड
२५.७७ करोड
२७.१४ करोड
२६.४८ करोड
Income tax expense
४.४९ करोड
५.५४ करोड
५.६४ करोड
५.३६ करोड
Effective tax rate
२०.४२%
२१.५०%
१९.५४%
२०.४९%
Other operating expenses
२३.११ करोड
२२.१० करोड
२४.१९ करोड
२५.४९ करोड
Net income
१२.६५ करोड
१४.६१ करोड
१९.४५ करोड
१५.३९ करोड
Net profit margin
८.५६%
९.४६%
१२.२६%
९.६३%
Earnings per share
१.२३
१.४६
१.६०
१.५५
Interest and investment income
-
-
-
-
Interest expense
-३.०८ करोड
-३.०२ करोड
-३.१८ करोड
-३.२८ करोड
Net interest expenses
-३.०८ करोड
-३.०२ करोड
-३.१८ करोड
-३.२८ करोड
Depreciation and amortization charges
८.२४ करोड
८.६४ करोड
८.७३ करोड
९.०४ करोड
EBITDA
३२.६० करोड
३६.९८ करोड
३८.८९ करोड
३७.८८ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू